Tandem Diabetes Care (TNDM) Total Debt Growth (3y) (2016 - 2018)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Total Debt Growth (3y) (2016 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | 24.63% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 4.06% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 4.89% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 11.72% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 0.11% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | 252.76% |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | - |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | -10.56% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 37.78% |
| Mar 31, 2018 | 37.39% |
| Dec 31, 2017 | 37.51% |
| Sep 30, 2017 | 36.97% |
| Jun 30, 2017 | 36.45% |
| Mar 31, 2017 | 35.81% |
| Dec 31, 2016 | 39.01% |